Billiontoone Inc (BLLN) Stock Price, Quote & News

Company Profile

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list o...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: (650) 460-2551

Website: www.billiontoone.com

Address:

1035 O’Brien Drive, Menlo Park, United States

sentinelles Mar. 14 at 8:31 PM

$BLLN Q4 2025 Earnings Success: BillionToOne recently reported record fiscal Q4 results, showing 113% year-over-year revenue growth

0 · Reply

Bazzzigar Mar. 14 at 5:53 PM

$BLLN BSX

0 · Reply

Bazzzigar Mar. 11 at 3:42 PM

$BLLN

1 · Reply

RayzorRay Mar. 10 at 5:49 PM

$BLLN should go under 60 then when lockup expires, might hit 40

0 · Reply

Bazzzigar Mar. 9 at 11:02 PM

$BLLN below $60?

1 · Reply

Khalident Mar. 5 at 6:29 PM

$BLLN why would anyone short companies trying to find a cure for diseases?

0 · Reply

v92 Mar. 5 at 5:19 PM

$BLLN if you want to be a millionaire, this is your stock!!!!! If you are starting as a billionaire. 🤣🤣🤣

0 · Reply

Bazzzigar Mar. 5 at 4:08 PM

$BLLN been warning

0 · Reply

Bazzzigar Mar. 5 at 3:44 PM

$BLLN JUNK

1 · Reply

erevnon Mar. 5 at 11:26 AM

BTIG maintains BillionToOne $BLLN at Buy and lowers the price target from $160 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

BillionToOne, Inc. (BLLN) Q4 2025 Earnings Call Transcript

Mar 6, 2026, 1:08 PM EST - 15 days ago

BillionToOne: Delivering And Lagging At The Same Time

Mar 4, 2026, 4:05 PM EST - 17 days ago

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

Feb 17, 2026, 8:05 AM EST - 4 weeks ago

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Feb 10, 2026, 9:00 AM EST - 5 weeks ago

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®

Feb 9, 2026, 12:29 PM EST - 5 weeks ago

BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care

Jan 15, 2026, 8:58 AM EST - 2 months ago

BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare

Jan 12, 2026, 8:05 AM EST - 2 months ago

BillionToOne Provides Guidance for 2026

Jan 6, 2026, 9:00 AM EST - 2 months ago

BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

Dec 23, 2025, 8:05 AM EST - 3 months ago

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 12, 2025, 5:12 PM EST - 3 months ago

BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call Transcript

Dec 9, 2025, 4:07 PM EST - 3 months ago

BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair

Dec 9, 2025, 4:05 PM EST - 3 months ago

BillionToOne Reports Third Quarter 2025 Results

Dec 2, 2025, 8:05 AM EST - 3 months ago

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025

Dec 1, 2025, 12:53 PM EST - 3 months ago

Analysts See Big Upside For Newly Listed Molecular Diagnostic Firm BillionToOne After Standout IPO Rally

Dec 1, 2025, 6:49 AM EST - 3 months ago

BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests

Nov 7, 2025, 3:17 AM EST - 4 months ago

BillionToOne: A Deserved Opening Day Boom

Nov 6, 2025, 5:02 PM EST - 4 months ago

Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering

Nov 6, 2025, 12:44 PM EST - 4 months ago

BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut

Nov 5, 2025, 10:36 PM EST - 4 months ago

Molecular diagnostics firm BillionToOne raises $273 million in US IPO

Nov 5, 2025, 9:53 PM EST - 4 months ago

BillionToOne Announces Pricing of Upsized Initial Public Offering

Oct 29, 2025, 6:00 AM EDT - 5 months ago

BillionToOne Announces Launch of Initial Public Offering Roadshow

Oct 17, 2025, 6:09 PM EDT - 5 months ago

BillionToOne targets over $2 billion valuation in US IPO

Oct 13, 2025, 12:23 PM EDT - 5 months ago

BillionToOne Launches IPO In Slowing IPO Market

Oct 11, 2025, 1:10 AM EDT - 5 months ago

U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown

ALH FFLY LFS POM PXED SONC TTRX

Oct 7, 2025, 6:17 PM EDT - 5 months ago

Molecular diagnostics firm BillionToOne files for US IPO

sentinelles Mar. 14 at 8:31 PM

$BLLN Q4 2025 Earnings Success: BillionToOne recently reported record fiscal Q4 results, showing 113% year-over-year revenue growth

0 · Reply

Bazzzigar Mar. 14 at 5:53 PM

$BLLN BSX

0 · Reply

Bazzzigar Mar. 11 at 3:42 PM

$BLLN

1 · Reply

RayzorRay Mar. 10 at 5:49 PM

$BLLN should go under 60 then when lockup expires, might hit 40

0 · Reply

Bazzzigar Mar. 9 at 11:02 PM

$BLLN below $60?

1 · Reply

Khalident Mar. 5 at 6:29 PM

$BLLN why would anyone short companies trying to find a cure for diseases?

0 · Reply

v92 Mar. 5 at 5:19 PM

$BLLN if you want to be a millionaire, this is your stock!!!!! If you are starting as a billionaire. 🤣🤣🤣

0 · Reply

Bazzzigar Mar. 5 at 4:08 PM

$BLLN been warning

0 · Reply

Bazzzigar Mar. 5 at 3:44 PM

$BLLN JUNK

1 · Reply

erevnon Mar. 5 at 11:26 AM

BTIG maintains BillionToOne $BLLN at Buy and lowers the price target from $160 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

BillionerOfKing Mar. 4 at 11:12 PM

$BLLN Current Stock Price: $80.42 Contracts to trade: $80.0 BLLN Mar 20 2026 Call Entry: $5.00 Exit: $8.51 ROI: 70% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Dieseld28 Mar. 4 at 11:08 PM

$BLLN BillionToOne Q3 EPS $0.10 Misses $0.16 Estimate, Sales $83.500M Beat $82.814M Estimate https://www.webull.com/news/13998972210430976

0 · Reply

StocktwitsEarnings Mar. 4 at 10:52 PM

$BLLN Q4 '25 Earnings Results & Recap BillionToOne expects full year 2026 revenue of $430M to $445M, representing 41% to 46% growth over 2025, and anticipates positive GAAP operating income for the full year 2026.

0 · Reply

StocktwitsEarnings Mar. 4 at 10:52 PM

$BLLN Q4 '25 Earnings Results & Recap BillionToOne raised its full year 2026 total revenue guidance to $430M to $445M, representing 41% to 46% growth over 2025, and expects positive GAAP operating income.

0 · Reply

Bazzzigar Mar. 4 at 9:21 PM

$BLLN as expected

1 · Reply

Bazzzigar Feb. 28 at 12:01 AM

$BLLN BSX

0 · Reply

Annie_Preferred Feb. 27 at 3:44 PM

$BLLN Geez ... maybe billion to one is how the stock price goes?

0 · Reply

Bazzzigar Feb. 25 at 6:21 PM

$BLLN as expected

0 · Reply

mollielatham Feb. 24 at 6:04 PM

$BLLN Cramer recommended this - was out at 90

1 · Reply

Annie_Preferred Feb. 24 at 2:05 AM

$BLLN As soon as it finds a bottom, I'll double up!

0 · Reply

prodigy81 Feb. 23 at 10:11 PM

$GRAL This looks very bad....huge loss now. Are the All others related to this such as $BLLN $HIMS and so on down because of that?

1 · Reply

Annie_Preferred Feb. 23 at 8:35 PM

$BLLN Dif tech than $GRAL!

0 · Reply

Market Cap	N/A
Revenue (ttm)	152.58M
Net Income (ttm)	-41.57M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	-27.24%
Debt to Equity Ratio	N/A

Volume	461,700
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	Strong Buy
Price Target	N/A